NCI Cancer Data Atlas System
The Cancer Data Access System ("CDAS") is a website where you may request data recorded from various research studies. For some studies, you may also request images or biospecimens.
CDAS provides extensive public documentation for each study, including a trial summary, an overview of the data collected, and a searchable database of research projects and publications.
If you are interested in obtaining study data, you may begin a CDAS project for that study. All projects are reviewed by NCI trial leadership. Upon approval, you will be granted access to the requested data and/or materials for a limited period.
The following studies are currently available on CDAS:
NLST: National Lung Screening Trial
This trial compared two ways of detecting lung cancer: low-dose helical computed tomography (CT) and standard chest X-ray. Both chest X-rays and low-dose helical CT scans have been used to find lung cancer early, but the effects of these screening techniques on lung cancer mortality rates had not been determined. NLST enrolled approximately 54,000 current or former heavy smokers from 33 sites and coordinating centers across the United States.
You can submit requests for: Study data, CT scan and digital pathology images. Biospecimens may be requested via an EEMS biospecimens request.
PLCO: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
This is a large-scale, randomized study to determine whether certain screening tests will reduce the number of deaths from these cancers. PLCO is being conducted at ten sites, geographically and demographically disparate, around the U.S. The Trial enrolled approximately 155,000 male and female participants between the ages of 55 and 74 from 1993 to 2001.
You can submit requests for: Study data, chest x-ray and digital pathology images, biospecimens, and preliminary applications for biospecimen project funding.
IDATA: Interactive Diet and Activity Tracking in AARP
This study examines the measurement error properties of instruments used for dietary and physical activity assessment in cohort studies. The investigators administered four dietary assessment instruments.
You can submit requests for: Study data and biospecimens.
The CDAS development team would like to acknowledge the National Heart, Lung, and Blood Institute
and its BioLINCC Program
for the programming code used in the implementation of this website. The CDAS code was based on the BioLINCC framework, which shares many of the same advanced features and a well-defined yet flexible workflow for request submission and fulfillment.
Share this Article with others
Caught in the crossfire: The critical threats facing cancer centers, research, and patient care. Shannon McWeeney PhD, & Sorena Nadaf-Rahrov MS, MMI
January 2025 Newsletter: The Year of Artificial Intelligence Sorena Nadaf-Rahrov, MS, MMI, PhDc
A recent Lancet study demonstrated that AI implementation led to a 29% increase in cancer detection, with no increase in false positives and a reduced workload compared to radiologists without AI assistance. While emerging evidence supports AI’s potential to enhance cancer detection in mammography screening and reduce screen-reading workload, further research is needed to fully understand its clinical impact.
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
With heavy hearts, we remember and honor Brady Davis, whose sudden passing leaves an immense void. Brady was a devoted supporter and invaluable contributor to the Cancer Center Informatics Society, dedicating countless hours to advancing our mission and strengthening our community. His expertise, enthusiasm, and unwavering commitment shaped our initiatives and inspired everyone fortunate enough to work alongside him. Brady’s legacy will live on through the progress he championed and the connections he fostered. We extend our deepest sympathies to his family, friends, and all who knew him. He will be greatly missed. In honor of Brady’s legacy, Ci4CC will be forming a committee to explore meaningful ways to memorialize him within our society for years to come. We plan to announce the committee’s recommendations at our Spring Summit in San Diego, CA, on March 31, 2025. Please find his obituary here , and visit his memorial page on MyKeeper to leave a tribute. Support the Davis family in Brady’s memory via GoFundMe ---------- Cancer Center Informatics Society (Ci4CC) Sorena Nadaf-Rahrov & Warren Kibbe Co-Founders, Ci4CC
Nature Digital Medicine PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models
American Cancer Society and Color Health to Provide Free At-Home Colorectal Cancer Screening in Underserved Rural Communities
Leading Progress Against Cancer
By Drs Karen Knudsen & Othman Laraki.
Conversation with The Cancer Letter: NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready” - July 12, 2024
